Hualan Biological Engineering Inc. (002007)

Overview

Hualan Biological Engineering Inc. is a leading biopharmaceutical company based in the People's Republic of China. Founded in 1992 and located in Xinxiang, the company is at the forefront of researching, developing, producing, and commercializing a wide range of biopharmaceutical products. Its portfolio includes plasma products, viral and bacterial vaccines, recombinant proteins, and other biologics. Hualan Biological has established strategic alliances with the Chinese Academy of Sciences, alongside other reputable scientific research institutes and companies, putting it at the cutting edge of biotechnological advancements in China.

Products and Services

The diverse range of products and services offered by Hualan Biological Engineering Inc. caters to various healthcare needs, from disease prevention to treatment. Below is a detailed overview of their main product categories:

• Blood Products: This category includes essential biologics such as human albumin, which is used to restore and maintain blood volume in the event of blood loss. Human immunoglobulin and intravenous human immunoglobulin are key for immune system support, addressing conditions like immune deficiencies. The company also provides rabies immunoglobulin for rabies exposure, hepatitis B human immunoglobulin for hepatitis B protection, and tetanus human immunoglobulin for tetanus infections. Other specialized products include human coagulation factor VIII for hemophilia, lyophilized human thrombin, and freeze-dried human fibrin glue for surgical applications, as well as human fibrinogen for blood clotting disorders.
• Vaccines: Hualan Biological's vaccine division produces various immunizations against infectious diseases. This includes the influenza virus split vaccine for seasonal flu prevention, recombinant hepatitis B vaccine for hepatitis B, and ACYW135 meningococcal polysaccharide vaccine for meningococcal disease. Additionally, the company offers an A H1N1 influenza virus split vaccine for swine flu and a quadrivalent influenza virus split vaccine, providing broader protection against four strains of influenza virus.